Abstract:Stroke leads to inflammatory and immune response in the brain and immune organs. The gut or gastrointestinal tract is a major immune organ equipped with the largest pool of immune cells representing more than 70% of the entire immune system and the largest population of macrophages in the human body. The bidirectional communication between the brain and the gut is commonly known as brain-gut or gut-brain axis. Stroke often leads to gut dysmotility, gut microbiota dysbiosis, "leaky" gut, gut hemorrhage, and even gut-origin sepsis, which is often associated with poor prognosis. Emerging evidence suggests that gut inflammatory and immune response plays a key role in the pathophysiology of stroke and may become a key therapeutic target for its treatment. Ischemic brain tissue produces damage-associated molecular patterns to initiate innate and adaptive immune response both locally and systemically through the specialized pattern-recognition receptors (e.g., toll-like receptors). After stroke, innate immune cells including neutrophils, microglia or macrophages, mast cells, innate lymphocytes (IL-17 secreting γδ T-cell), and natural killer T-cell respond within hours, followed by the adaptive immune response through activation of T and B lymphocytes. Subpopulations of T-cells can help or worsen ischemic brain injury. Pro-inflammatory Th1, Th17, and γδ T-cells are often associated with increased inflammatory damage, whereas regulatory T-cells are known to suppress postischemic inflammation by increasing the secretion of anti-inflammatory cytokine IL-10. Although known to play a key role, research in the gut inflammatory and immune response after stroke is still in its initial stage. A better understanding of the gut inflammatory and immune response after stroke may be important for the development of effective stroke therapies. The present review will discuss recent advances in the studies of the brain-gut axis after stroke, the key issues to be solved, and the future directions.

Gut-brain axis: Mechanisms and potential therapeutic strategies for ischemic stroke through immune functions

Role of the gut microbiota in complications after ischemic stroke

Cellular Immune Signal Exchange From Ischemic Stroke to Intestinal Lesions Through Brain-Gut Axis

Systemic immune responses after ischemic stroke: From the center to the periphery

The role of IL-23/IL-17 axis in ischemic stroke from the perspective of gut-brain axis

Brain–gut axis after stroke

Immune regulation of the gut-brain axis and lung-brain axis involved in ischemic stroke

The gastrointestinal-brain-microbiota axis: a promising therapeutic target for ischemic stroke

Influence of the brain‐gut axis on neuroinflammation in cerebral ischemia‐reperfusion injury (Review)

Microbiota Metabolites and Immune Regulation Affect Ischemic Stroke Occurrence, Development, and Prognosis

Therapeutic approaches targeting the gut microbiota in ischemic stroke: current advances and future directions

The Involvement of Immune Cells Between Ischemic Stroke and Gut Microbiota

Crosstalk between the Gut and Brain in Ischemic Stroke: Mechanistic Insights and Therapeutic Options

How Brain Infarction Links With the Microbiota–Gut–Brain Axis: Hints From Studies Focusing on the Risk Factors for Ischemic Stroke

Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites

Novel Mechanisms and Therapeutic Targets for Ischemic Stroke: A Focus on Gut Microbiota

The interaction between intestinal microenvironment and stroke

Bidirectional Gut-Brain-microbiota Axis As a Potential Link Between Inflammatory Bowel Disease and Ischemic Stroke

Mechanisms of immune response and cell death in ischemic stroke and their regulation by natural compounds

Ischemic stroke and intestinal flora: an insight into brain–gut axis

Could the Gut Microbiota Serve as a Therapeutic Target in Ischemic Stroke?